Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

12.1K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.1K
Neurotransmitters01:31

Neurotransmitters

3.9K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
3.9K
Neurotransmitters01:30

Neurotransmitters

9.8K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
9.8K
Chemical Synapses01:26

Chemical Synapses

10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

The international journal of neuropsychopharmacology·2026
Same author

Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Emotion Regulation and Attachment Style as Predictors of Psychiatric Hospitalization Duration in Suicidal Adolescents.

Children (Basel, Switzerland)·2026
Same author

A novel multidimensional dynamic difficulty adjustment algorithm: Use case in a cognitive training video game.

Psychological methods·2026
Same author

Corrigendum to "The paradoxical protective effect of chronic stress on advanced Alzheimer's disease pathology". [Brain, Behav., Immun. 132 (2026) 106224].

Brain, behavior, and immunity·2026
Same author

Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration.

Acta neuropsychiatrica·2026
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Related Experiment Video

Updated: Apr 29, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.7K

Neurotransmitters and electroconvulsive therapy.

Pia Baldinger1, Amit Lotan, Richard Frey

  • 1From the *Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria and †Biological Psychiatry Laboratory at Hadassah, Hebrew University Medical Center, Jerusalem, Israel.

The Journal of ECT
|May 14, 2014
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) enhances serotonin and dopamine systems, crucial for treating depression. These findings from preclinical and human studies clarify ECT's neurobiological effects, aiding future treatment development.

More Related Videos

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.9K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K

Related Experiment Videos

Last Updated: Apr 29, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.7K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.9K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K

Area of Science:

  • Neuroscience
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is effective for treatment-resistant depression.
  • The precise neurobiological mechanisms of ECT remain incompletely understood.
  • ECT impacts neurotransmission systems implicated in depression, particularly serotonin and dopamine.

Purpose of the Study:

  • To review the neurobiological effects of electroconvulsive seizures (ECS) and ECT on serotonin and dopamine systems.
  • To synthesize findings from preclinical and human studies on ECT's impact on neurotransmission.

Main Methods:

  • Searched PubMed for preclinical and human studies on ECS/ECT effects on serotonergic and dopaminergic systems.
  • Included studies using behavioral, molecular, electrophysiological, and imaging techniques.
  • Reviewed genetic association studies and human data on neurotransmitter turnover and receptor binding.

Main Results:

  • 40 studies examined ECS/ECT and serotonin; only 3 were in humans.
  • 15 preclinical and 12 human studies investigated ECS/ECT and dopamine.
  • Preclinical and human data show ECS/ECT enhances serotonergic neurotransmission and activates the mesolimbic dopamine system.

Conclusions:

  • Human genetic and imaging studies support preclinical findings on ECT's effects on serotonin and dopamine.
  • ECT's impact is observed at multiple levels: neurotransmitter release, receptor binding, and overall neurotransmission.
  • Further research combining modalities can elucidate ECT's antidepressant mechanisms and inform new treatments.